Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Fat tissue and a specific protein are crucial for healthy hair growth and maintenance.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Men with early hair loss may have higher health risks similar to women with PCOS.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.